ANTHROGENESIS

DEAD

Serial Number

76396674

Owner

Celgene Corporation

Attorney

Camille M. Miller

Filing Date

Apr 16, 2002

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ANTHROGENESIS Trademark

Serial Number: 76396674 • Registration: 2768841

ANTHROGENESIS is a trademark filed by Celgene Corporation on April 16, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

CELULARITY, INC. (50 trademarks)

33 TECHNOLOGY DRIVE
WARREN, NJ 07059

Entity Type: 03

ANTHROGENESIS CORPORATION (4 trademarks)

45 HORSEHILL ROAD
CEDAR KNOLLS, NJ 07927

Entity Type: 03

Legal Representation

Attorney of Record

Camille M. Miller

6,734 trademarks filed View all →

Trademark Details

Filing Date

April 16, 2002

Registration Date

September 30, 2003

Published for Opposition

July 8, 2003

Cancellation Date

April 12, 2024

Goods & Services

biological tissue intended for subsequent implantation namely, blood, stem cells, umbilical cords and placentas for medical and clinical use

biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific, laboratory and medical research

collection and preservation of human blood, umbilical cord blood, stem cells, umbilical cords and placentas

development of new technology for others in the field of genomics, biotechnology

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Apr 12, 2024 CAEX

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Sep 30, 2022 REM2

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jan 12, 2022 ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

May 23, 2018 ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Dec 13, 2017 ASGN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 28, 2015 TCCA

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Oct 20, 2012 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Oct 20, 2012 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Oct 20, 2012 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Oct 20, 2012 APRE

TEAS SECTION 8 & 9 RECEIVED

Oct 2, 2012 E89R

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

May 7, 2009 C15A

RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 15

Feb 9, 2009 PR23

PAPER RECEIVED

Feb 9, 2009 MAIL

ASSIGNED TO PARALEGAL

Feb 5, 2009 PLGL

TEAS SECTION 8 & 15 RECEIVED

Feb 3, 2009 E815

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

Jan 28, 2009 PR23

ASSIGNED TO PARALEGAL

Oct 6, 2008 PLGL

TEAS SECTION 8 & 15 RECEIVED

Oct 2, 2008 E815

CASE FILE IN TICRS

Aug 14, 2008 CFIT

REGISTERED-PRINCIPAL REGISTER

Sep 30, 2003 R.PR

PUBLISHED FOR OPPOSITION

Jul 8, 2003 PUBO

NOTICE OF PUBLICATION

Jun 18, 2003 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 17, 2003 CNSA

EXAMINERS AMENDMENT MAILED

Apr 11, 2003 CNEA

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 7, 2003 CRFA

PAPER RECEIVED

Feb 7, 2003 MAIL

UNRESPONSIVE/DUPLICATE PAPER RECEIVED

Jan 30, 2003 UNPR

PAPER RECEIVED

Jan 30, 2003 MAIL

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 10, 2003 TCCA

NON-FINAL ACTION MAILED

Aug 13, 2002 CNRT

ASSIGNED TO EXAMINER

Aug 8, 2002 DOCK

Related Trademarks

More from this Owner

More in Same Class

BIFIDUR

CENTENARIUS